Keywords: unique, benefit, profile, faust, pd, drug, strasbourg

Unique benefit profile for Faust's PD drug

Article | 11 June 2007

Print This

Strasbourg, France-based Faust Pharmaceuticals SA says that results from a Phase IIa trial of FP0011, were presented at the 11th ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in